Literature DB >> 931403

Diffuse eosinophilic fasciitis. A new syndrome or variant of Scleroderma?

V M Torres, W M George.   

Abstract

Recently, attention has been drawn to a scleroderma-like illness, characterized by transient eosinophilia, which is commonly antedated by unusual physical exertion, is apparently free from significant systemic changes, and in which the primary pathological alterations, consisting of intense inflammation and thickening with or without eosinophils, occur initially in the fascia, not the skin. These patients are said to respond well to oral corticosteroids and an occasional one may undergo spontaneous resolution. Clinicopathologic study of a patient with this syndrome, suggests an even deeper tissue genesis than that recently proposed for some of the cutaneoindurative disorders. Eosinophilic fasciitis probably represents an impressive, but perhaps relatively benign variant of diffuse scleroderma, according to reported cases.

Entities:  

Mesh:

Year:  1977        PMID: 931403     DOI: 10.1001/archderm.113.11.1591

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Eosinophilic fasciitis: a rare skin sclerosis.

Authors:  Amandine Servy; Thierry Clérici; Caroline Malines; Jean-Marie Le Parc; Jean-François Côté
Journal:  Patholog Res Int       Date:  2010-12-01

2.  Eosinophilic fasciitis in association with chronic vasculitic-like leg ulcerations.

Authors:  A L Wong; N Anderson-Wilms; S E Mortensen; K K Colburn
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

3.  [Eosinophilic fasciitis (Shulman syndrome)].

Authors:  P Herzer; H S Füessl; M Meurer; M Schattenkirchner
Journal:  Klin Wochenschr       Date:  1982-11-02

4.  Eosinophilic fasciitis. A pathologic study of twenty cases.

Authors:  L Barnes; G P Rodnan; T A Medsger; D Short
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

Review 5.  Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome.

Authors:  Yukie Endo; Atsushi Tamura; Youichiro Matsushima; Tomoko Iwasaki; Michiko Hasegawa; Yayoi Nagai; Osamu Ishikawa
Journal:  Clin Rheumatol       Date:  2007-03-08       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.